Navigation Links
Anti-tumor drugs tested by microfluidic device
Date:10/5/2010

Washington, D.C. (October 5, 2010) -- A prototype device developed in Hong Kong will allow laboratory researchers to non-invasively test drugs for their ability to kill tumors by subjecting cancerous cells with different concentration gradients. The new device is built upon microfluidics -- a set of technologies that allows the control and manipulation of fluids at the sub-millimeter scale -- and is described in the American Institute of Physics' journal Biomicrofluidics.

Microfluidic valves within the device, said Hongkai Wu of Hong Kong University of Science and Technology, accurately meter different solutions and mix them to form a stepwise succession of gradients. Then assays measuring cell apoptosis are applied. The device integrates a previously validated analysis method that quantifies the apoptotic process at the level of single cells in real-time.

For this test, researchers measured the activity of the drug etoposide in HeLa cells. Etoposide is a commercially available anticancer compound commonly used in chemotherapy. HeLa cells, derived from human cervical cancer cells, are a line of cells frequently used in research.

The device allows researchers to study the cytotoxicity of multiple concentrations of a drug in parallel on one chip, saving both time and labor and reducing errors caused by variations in conditions often found in larger-scale testing. Also, microfluidic chambers within the device allow long-term tracking of individual cells through fluorescent microscopic imaging that offers high optical sensitivity.

With some other in vitro tests, like DNA analysis, cells need to be killed in order to be studied. In this analysis method, a change in fluorescence occurs when caspase-3, an indicator of cell apoptosis, is activated. In Wu's test, increasing concentrations of etoposide demonstrated correspondingly higher activation of caspase-3. In a control-group chip without etoposide, caspase-3 was not activ
'/>"/>

Contact: Jason Bardi
jbardi@aip.org
301-209-3091
American Institute of Physics
Source:Eurekalert

Page: 1 2

Related biology news :

1. Researchers identify new anti-tumor gene
2. Childrens National researchers develop novel anti-tumor vaccine
3. Iowa State, Ames Lab researchers identify structure that allows bacteria to resist drugs
4. White House policy advisor talks about legalized drugs
5. Ingredient in soap points toward new drugs for infection that affects 2 billion
6. Case Western Reserve researcher discovers new anti-pathogenic drugs to treat MRSA
7. Scripps scientists develop test providing new pathway for identifying obesity, diabetes drugs
8. U of M researchers identify 2 FDA approved drugs that may fight HIV
9. Scientists reveal new targets for anti-angiogenesis drugs
10. Drugs encased in nanoparticles travel to tumors on the surface of immune-system cells
11. Molecules delivering drugs as they walk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... disease and other forms of dementia, but the research ... University of Washington bioengineers have a designed a peptide ... body,s normal proteins into a state that,s linked to ... 2 diabetes and Lou Gehrig,s disease. The synthetic molecule ... state into an abnormally folded form by targeting a ...
(Date:7/28/2014)... researchers are using magnetic beads and DNA "springs" to ... as microscale models for polymer macromolecules. , The experiment ... in the 1950s, can be made as stiff or ... to materials scientists who study the basic physics of ... biomolecular engineer Sibani Lisa Biswal and graduate student Julie ...
(Date:7/28/2014)... 15% of adults suffer from fertility problems, many of ... a paradox: We might expect such genes, which reduce ... population. Research at the Weizmann Institute of Science that ... have solved this riddle. Not only can it explain ... open new avenues in understanding the causes of genetic ...
Breaking Biology News(10 mins):New protein structure could help treat Alzheimer's, related diseases 2New protein structure could help treat Alzheimer's, related diseases 3Seeing is bead-lieving 2Mutations from Venus, mutations from Mars 2
... is part of a team that has discovered a new ... that could be repeated in cells of other organisms. , ... the Department of Chemistry at UCR, worked with Feng Xu ... the David Geffen School of Medicine at UCLA on a ...
... that exposure to second-hand smoke during pregnancy can be ... exposure through maternal smoking, according to a recent paper ... Health. , In a study published in the online ... of environmental and occupational health, reports that both active ...
... to 100 billion neurons, and each has hundreds of ... connections is essential to understanding brain function, and the ... new theoretical approach to mapping neuron connectivity published in ... the Department of Neuroscience at the University of Minnesota, ...
Cached Biology News:UCR chemist part of team identifying new areas of gene regulation 2Any exposure to tobacco smoke during pregnancy is risky 2
(Date:7/28/2014)... Texas (PRWEB) July 28, 2014 ... and China Lubricant Industry” is a professional ... Global Lubricant market. The report introduces Lubricant ... and industry chain structure and industry overview. ... including China’s domestic market as well as ...
(Date:7/28/2014)... and Annapolis Junction, MD (PRWEB) July 28, 2014 ... research leader in personalized medicine, will be exhibiting data ... at this year’s International Spine Intervention Society’s ... place July 30th-August 3rd, at the Hyatt Regency, in ... to enhance the knowledge and clinical competence of physicians ...
(Date:7/28/2014)... 28, 2014 /PRNewswire/ -   JOLT , a leading ... to join its growing portfolio of startups. Next-level tech ... Toronto,s JOLT accelerator, and Cohort four is ... Since its launch in July 2012, ...  $7.5M of financing. Now at 23 investments, JOLT,s portfolio ...
(Date:7/28/2014)... 28, 2014  David Hardison, Ph.D., vice president ... , has been elected chairman of the board ... non-profit working to establish common protocols around the ... relates to electronic health records. ... collaborating with organizations across the research and health ...
Breaking Biology Technology:Lubricant Market & Adhesion Promoter Industry (Globa, China) Analysis Now Available at DeepResearchReports.com 2Lubricant Market & Adhesion Promoter Industry (Globa, China) Analysis Now Available at DeepResearchReports.com 3Lubricant Market & Adhesion Promoter Industry (Globa, China) Analysis Now Available at DeepResearchReports.com 4Proove Biosciences Exhibits Industry Leading Data and Research at International Spine Intervention Society’s 22nd Annual Scientific Meeting 2JOLT Announces the Next 6 Startups to Join its Summer 2014 Cohort 2JOLT Announces the Next 6 Startups to Join its Summer 2014 Cohort 3ConvergeHEALTH by Deloitte's David Hardison Named Chairman of the Clinical Data Interchange Standards Consortium 2ConvergeHEALTH by Deloitte's David Hardison Named Chairman of the Clinical Data Interchange Standards Consortium 3
... pro-apoptotic agent presented at the 100th Annual Meeting ... University of Pennsylvania data on chemotherapy ... inhibition of Mcl-1, also presented - MALVERN, Pa., ... the results of preclinical studies of its orally-active, ...
... a leading provider of room-temperature biosample transport, storage ... GenConnect 3.2, the newest version of its software ... release include a strategic licensing model that enables ... offerings, as well as a new customer licensing ...
... ProLindac should provide sustained tumor exposure to platinum and ... in the clinic -DALLAS, April 21 ACCESS ... announced today that its collaborators at Centre Rene Huguenin ... anticancer compound, ProLindac(TM), at the American Association for Cancer ...
Cached Biology Technology:Ascenta Therapeutics Announces Results of Preclinical Evaluation of AT-406 in Multiple Cancer Models 2Ascenta Therapeutics Announces Results of Preclinical Evaluation of AT-406 in Multiple Cancer Models 3GenVault Corporation Launches its Latest Centralized and Standardized Software Solution for Biobanking and Biological Sample Management, GenConnect 3.2 2GenVault Corporation Launches its Latest Centralized and Standardized Software Solution for Biobanking and Biological Sample Management, GenConnect 3.2 3Access Pharmaceuticals Presents New Data on ProLindac(TM) at the 2009 AACR Annual Meeting 2Access Pharmaceuticals Presents New Data on ProLindac(TM) at the 2009 AACR Annual Meeting 3Access Pharmaceuticals Presents New Data on ProLindac(TM) at the 2009 AACR Annual Meeting 4
karyopherin alpha2 (2G7)...
... The PowerEase 500 Power Supply ... electrophoresis. It offers extensive programming ... four custom methods for you ... preferences. The simple intuitive PowerEase ...
... real-time or pre-programmed liquid switching ... or general liquid-handling research applications. ... accuracy. Run experiments ... Microprocessor-based for accuracy and flexibility ...
... entry-level automated perfusion system. For real-time ... physiology, biophysics, electrochemistry, or general liquid-handling ... 10 millisecond accuracy Run experiments ... for accuracy and flexibility Turnkey ...
Biology Products: